Document Detail


The dynamic insulin sensitivity and secretion test-a novel measure of insulin sensitivity.
MedLine Citation:
PMID:  21704347     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The objective was to validate the methodology for the dynamic insulin sensitivity and secretion test (DISST) and to demonstrate its potential in clinical and research settings. One hundred twenty-three men and women had routine clinical and biochemical measurements, an oral glucose tolerance test, and a DISST. For the DISST, participants were cannulated for blood sampling and bolus administration. Blood samples were drawn at t = 0, 10, 15, 25, and 35 minutes for measurement of glucose, insulin, and C-peptide. A 10-g bolus of intravenous glucose at t = 5 minutes and 1 U of intravenous insulin immediately after the t = 15 minute sample were given. Fifty participants also had a hyperinsulinemic-euglycemic clamp. Relationships between DISST insulin sensitivity (SI) and the clamp, and both DISST SI and secretion and other metabolic variables were measured. A Bland-Altman plot showed little bias in the comparison of DISST with the clamp, with DISST underestimating the glucose clamp by 0.1·10(-2)·mg·L·kg(-1)·min(-1)·pmol(-1) (90% confidence interval, -0.2 to 0). The correlation between SI as measured by DISST and the clamp was 0.82; the c unit for the receiver operating characteristic curve analysis for the 2 tests was 0.96. Metabolic variables showed significant correlations with DISST SI and the second phase of insulin release. The DISST also appears able to distinguish different insulin secretion patterns in individuals with identical SI values. The DISST is a simple, dynamic test that compares favorably with the clamp in assessing SI and allows simultaneous assessment of insulin secretion. The DISST has the potential to provide even more information about the pathophysiology of diabetes than more complicated tests.
Authors:
Kirsten A McAuley; Juliet E Berkeley; Paul D Docherty; Thomas F Lotz; Lisa A Te Morenga; Geoff M Shaw; Sheila M Williams; J Geoffrey Chase; Jim I Mann
Related Documents :
21764087 - Can informed choice invitations lead to inequities in intentions to make lifestyle chan...
18583417 - Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated dba/2j mice.
20109477 - Effect of insulin on the relationship of estrous behaviors to estradiol and lh surges i...
2285307 - Influence of water activity and temperature on survival of and colony formation by heat...
7800207 - Similar rate of progression in the predialysis phase in type i and type ii diabetes mel...
17491147 - Metabolism of the bovine cumulus-oocyte complex and influence on subsequent development...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-23
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  -     ISSN:  1532-8600     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Edgar National Centre for Diabetes and Obesity Research, University of Otago, Dunedin 9054, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heavy metal concentrations and biomarkers of oxidative stress in native mussels (Mytilus edulis chil...
Next Document:  Overexpression of hepatic 5?-reductase and 11?-hydroxysteroid dehydrogenase type 1 in visceral adipo...